Europe Pharmaceutical Glass Vials And Ampoules Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2031)

The Europe Pharmaceutical Glass Vials and Ampoules Market Report is Segmented by Product Type (Vials, Ampoules) and Country (Germany, Italy, France, United Kingdom, Spain, and Rest of Europe). The Market Sizes and Forecasts are Provided in Terms of Value (USD) for all the Above Segments.

Europe Pharmaceutical Glass Vials And Ampoules Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2031)

Europe Pharmaceutical Glass Vials And Ampoules Market Size

Europe Pharmaceutical Glass Vials And Ampoules Market Summary
Study Period 2019 - 2031
Base Year For Estimation 2024
Forecast Data Period 2025 - 2031
Market Size (2025) USD 0.84 Billion
Market Size (2031) USD 1.16 Billion
CAGR (2025 - 2031) 5.42 %
Market Concentration Medium

Major Players

Europe Pharmaceutical Glass Vials And Ampoules Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Europe Pharmaceutical Glass Vials And Ampoules Market with other markets in Packaging Industry

Advanced Packaging

Packaging Equipment

Contract Packaging

Overall Packaging

Packaging Customers

Packaging Forms

Europe Pharmaceutical Glass Vials And Ampoules Market Analysis

The Europe Pharmaceutical Glass Vials And Ampoules Market size is estimated at USD 0.84 billion in 2025, and is expected to reach USD 1.16 billion by 2031, at a CAGR of 5.42% during the forecast period (2025-2031).

  • Glass has long been the preferred material in Europe's pharmaceutical packaging industry, ensuring the safe containment of medicines. Its chemical stability and inertness make it suitable for packaging a range of products, from solids and liquids to injectables and reconstitutes. Moreover, glass's resistance to temperature fluctuations is crucial for the pharmaceutical sector, where maintaining specific temperatures is often paramount. This quality becomes even more vital during processes like sterilization, freezing, or freeze-drying, which can be particularly 'stressful' for packaging.
  • Glass vials, typically manufactured from borosilicate glass, serve as small containers for storing medications, whether in liquid or powder form. Borosilicate glass's resistance to thermal shock and chemical reactions ensures the stability and safety of the stored medication. These vials find common use in the pharmaceutical sector, especially for packaging vaccines, biologics, and other injectable drugs. The rising demand for safe and reliable packaging, particularly in the expanding biologics and vaccine sectors, drives the glass vial market in Europe.
  • Ampoules, sealed glass capsules designed for injections, contain liquid medication. They feature a neck that can be snapped off, ensuring a single-use, sterile environment. This design is vital for preserving the efficacy and safety of injectable drugs. Widely utilized for storing and transporting sensitive medications, ampoules guarantee contamination-free storage until use. The expanding market for ampoules is fueled by the growing demand for single-dose packaging and the rising prevalence of chronic diseases necessitating injectable treatments.
  • As demand for high-value parenteral drugs surges, pharmaceutical companies face mounting pressure to expedite their market entry. In October 2023, SGD Pharma unveiled an expansion of its Sterinity range, introducing new sizes to its Ready-To-Use (RTU) Type I molded glass vials. Adding 10H ml and 20H ml sizes in trays offers customers enhanced flexibility, addressing specific requests for high-quality sterile vials tailored to parenteral drugs' aseptic fill/finish.
  • There's a growing trend toward recycled glass products in Europe, particularly Type II and Type III glass. These utilize materials sourced from an external supply chain and are certified for pharmaceutical use. These recycled materials regenerate through chemical and mechanical processing into glass powder, forming the foundation for a new processing cycle. Concurrently, initiatives are underway to develop low-emission furnaces, leveraging innovative technologies and industrial processes to minimize environmental impact.

Europe Pharmaceutical Glass Vials And Ampoules Industry Overview

The European pharmaceutical glass vials and ampoules market is fragmented, with the presence of major players like Schott AG, Gerresheimer AG, Stevanato Group, SGD SA, and Bormioli Pharma SA. Players in the market are adopting strategies such as partnerships and acquisitions to enhance their product offerings and gain sustainable competitive advantage. These strategies help companies to expand their market presence, enhance their product portfolios, and meet the diverse needs of consumers. The continuous efforts to innovate and improve packaging solutions are expected to further propel the growth of the pharmaceutical glass vials and ampoules market.

Europe Pharmaceutical Glass Vials And Ampoules Market Leaders

  1. Scott Pharma (Scott AG)

  2. Gerresheimer AG

  3. Stevanato Group

  4. SGD S.A.

  5. Bormioli Pharma S.p.A.

  6. *Disclaimer: Major Players sorted in no particular order
Europe Pharmaceutical Glass Vials And Ampoules Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Europe Pharmaceutical Glass Vials And Ampoules Market News

  • May 2024: Gerresheimer Glas GmbH, an indirect subsidiary of Gerresheimer AG, inked a purchase agreement with funds advised by Triton ("Triton") to acquire Blitz LuxCo Sarl, the holding entity of the Bormioli Pharma Group ("Bormioli Pharma"). The agreed purchase price hinges on an enterprise value pegged at approximately EUR 800 million (USD 883.24 million). Bormioli Pharma's diverse portfolio encompasses pharmaceutical primary packaging crafted from both glass and plastic, alongside closure solutions, accessories, and dispensing systems. Through this acquisition, Gerresheimer bolsters its presence in Europe, particularly in Southern regions, and solidifies its stature as a premier full-service provider and global ally to the pharmaceutical and biotech sectors.
  • January 2024: SGD Pharma boosted capacity for siliconized glass vials with a new line. The company inaugurated a new siliconisation operation at its Saint-Quentin Lamotte (SQLM) facility in France. By bringing glass silicification in-house, the company bolsters its already comprehensive suite of services, ensuring quicker responses, a secure supply chain, and greater flexibility in vial sizes. The newly established operation at SQLM can handle all glass types, accommodating vial sizes from 3 ml to 500 ml in both clear and amber variants, all while maintaining a high processing capacity. This treatment caters to diverse market needs, including applications in anti-infectives, parenteral nutrition, diagnostics, animal health, and oncology.

Europe Pharmaceutical Glass Vials And Ampoules Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.2.1 Bargaining Power of Suppliers
    • 4.2.2 Bargaining Power of Consumers
    • 4.2.3 Threat of New Entrants
    • 4.2.4 Threat of Substitute Products
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Export Import Data of Glass Ampoules for Major Economies, Trade Data
  • 4.4 Overview on Pharmaceutical Glass Types (Type I, Type II, and Type III)
  • 4.5 Overview on Pharmaceuticals Glass Vials and Ampoules regulations

5. MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Investments in Pharmaceutical Industry in the Region
    • 5.1.2 The rising Trend of Sustainable Packaging Significant Growth Opportunities
  • 5.2 Market Challenge
    • 5.2.1 Higher Carbon Footprint Glass Manufacturing Hampers Market Growth

6. MARKET SEGMENTATION

  • 6.1 By Product Type
    • 6.1.1 Vials
    • 6.1.2 Ampoules
  • 6.2 By Geography***
    • 6.2.1 Germany
    • 6.2.2 Italy
    • 6.2.3 France
    • 6.2.4 United Kingdom
    • 6.2.5 Spain

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Scott Pharma (Scott AG)
    • 7.1.2 Gerresheimer AG
    • 7.1.3 Stevanato Group
    • 7.1.4 SGD S.A.
    • 7.1.5 DWK Life Sciences
    • 7.1.6 Bormioli Pharma S.p.A.
    • 7.1.7 NAFVSM B.V.
    • 7.1.8 Soffieria Bertolini S.p.A.
    • 7.1.9 SFAM Group
    • 7.1.10 Origin Pharma Packaging
    • 7.1.11 Alphial S.r.l.
  • *List Not Exhaustive
  • 7.2 Heat Map Analysis

8. RECYCLING & SUSTAINABILITY LANDSCAPE**

9. FUTURE OUTLOOK

**Subject to Availability
*** In the final study, Rest of Europe will be added as a separate segment.
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Europe Pharmaceutical Glass Vials And Ampoules Industry Segmentation

The scope of the study characterizes the pharmaceutical glass vials and ampoules market based on product type, including vials and ampoules. A vial is a compact container designed to hold liquid medications, serums, and various pharmaceutical compounds. An ampoule, a smaller variant, serves as a single-dose vial with a sealed neck. The research examines underlying growth influencers and significant industry vendors, all of which help to support market estimates and growth rates throughout the anticipated period. The market estimates and projections are based on the base year factors and arrived at top-down and bottom-up approaches.

The European pharmaceutical glass vials and ampoules market is segmented by product type (vials, ampoules) and country (Germany, Italy, France, United Kingdom, Spain, and the Rest of Europe). The market sizes and forecasts are provided in terms of value (USD) for all the above segments.

By Product Type Vials
Ampoules
By Geography*** Germany
Italy
France
United Kingdom
Spain
Need A Different Region or Segment?
Customize Now

Europe Pharmaceutical Glass Vials And Ampoules Market Research FAQs

How big is the Europe Pharmaceutical Glass Vials And Ampoules Market?

The Europe Pharmaceutical Glass Vials And Ampoules Market size is expected to reach USD 0.84 billion in 2025 and grow at a CAGR of 5.42% to reach USD 1.16 billion by 2031.

What is the current Europe Pharmaceutical Glass Vials And Ampoules Market size?

In 2025, the Europe Pharmaceutical Glass Vials And Ampoules Market size is expected to reach USD 0.84 billion.

Who are the key players in Europe Pharmaceutical Glass Vials And Ampoules Market?

Scott Pharma (Scott AG), Gerresheimer AG, Stevanato Group, SGD S.A. and Bormioli Pharma S.p.A. are the major companies operating in the Europe Pharmaceutical Glass Vials And Ampoules Market.

What years does this Europe Pharmaceutical Glass Vials And Ampoules Market cover, and what was the market size in 2024?

In 2024, the Europe Pharmaceutical Glass Vials And Ampoules Market size was estimated at USD 0.79 billion. The report covers the Europe Pharmaceutical Glass Vials And Ampoules Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Europe Pharmaceutical Glass Vials And Ampoules Market size for years: 2025, 2026, 2027, 2028, 2029, 2030 and 2031.

Europe Pharmaceutical Glass Vials And Ampoules Industry Report

Statistics for the 2025 Europe Pharmaceutical Glass Vials And Ampoules market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Pharmaceutical Glass Vials And Ampoules analysis includes a market forecast outlook for 2025 to 2031 and historical overview. Get a sample of this industry analysis as a free report PDF download.